Comments

Regeneron Pharmaceuticals Stock Price, Quotes and Forecasts

Q: What sector and industry does Regeneron Pharmaceuticals (REGN) operate in?

Regeneron Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

REGNNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$527.78

-19.89-3.63%

At close: -

$529.40

1.620.31%

After Hours: May 9, 6:03 PM EDT

The dividend Ex-Date is in 9 days

Regeneron Pharmaceuticals (REGN) Forecast

News Earnings Regeneron Pharmaceuticals (REGN) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Regeneron Pharmaceuticals Stock Price, Quotes and Forecasts | NASDAQ:REGN | Benzinga

Explore Regeneron Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for REGN.

Open	$549.00
Close	$527.78
Volume / Avg.	1.50M / 1.09M
Day Range	$527.13 - $552.84
52 Wk Range	520.50 - 1.21K
Market Cap	$57.16B
P/E Ratio	13.92
Dividend Yield	0.64%
Exchange	NASDAQ
RSI	35
Short Interest	2.82%
Days to Cover	2.41

Recent News

Eli Lilly, Affirm And Regeneron Are Among Top 12 Large-Cap Losers Last Week (May 5-May 9): Are The Others In Your Portfolio?

The worst performing large-cap stocks last week: ARGENX, VRTX, SMMT, MMYT, REGN, RKT, BNTX, AFRM, FNF, LLY, AUR, DASH. Any in your portfolio?

Lekha Gupta

FDA Expands Surprise Inspections At Foreign Drug And Food Facilities, Targets Double Standards In Overseas Manufacturing Oversight

FDA to increase surprise inspections at foreign facilities as U.S. companies pour billions into domestic drug and device manufacturing.

Vandana Singh

Why Is Israel-Based Generic Drug Focused Teva Pharmaceutical Stock Trading Higher On Monday?

FDA approves Teva and Alvotech's Selarsdi as an interchangeable biosimilar to Stelara, supporting the treatment of multiple chronic inflammatory diseases.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jan

Feb

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$549.00
Close	$527.78
Volume / Avg.	1.50M / 1.09M
Day Range	$527.13 - $552.84
52 Wk Range	520.50 - 1.21K
Market Cap	$57.16B
P/E Ratio	13.92
Dividend Yield	0.64%
Exchange	NASDAQ
RSI	35
Short Interest	2.82%
Days to Cover	2.41

About Regeneron Pharmaceuticals, Inc.

Sector

Health Care

Industry

Biotechnology

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, c...

Got Questions? Ask

How is the earnings season affecting REGN?

What is REGN's all-time high price?

What is REGN's dividend yield?

What is REGN's net income trend?

What’s the latest news on REGN?

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Regeneron Pharmaceuticals (REGN) stock?

You can purchase shares of Regeneron Pharmaceuticals (NASDAQ:REGN) through any online brokerage.

View our list of the best stock brokerages

Who are Regeneron Pharmaceuticals (REGN) competitors?

Other companies in Regeneron Pharmaceuticals’s space includes: BeiGene (NASDAQ:ONC), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).

What is the forecast, or price target, for Regeneron Pharmaceuticals (REGN) stock?

Regeneron Pharmaceuticals has a consensus price target of $925.03.

What is the current price for Regeneron Pharmaceuticals (REGN)?

The stock price for Regeneron Pharmaceuticals (NASDAQ: REGN) is $529.4 last updated May 9, 2025 at 6:03 PM EDT.

Does Regeneron Pharmaceuticals (REGN) pay a dividend?

The next Regeneron Pharmaceuticals (REGN) dividend date is projected to be Tuesday, May 20, 2025.

When is Regeneron Pharmaceuticals (NASDAQ:REGN) reporting earnings?

Regeneron Pharmaceuticals’s Q2 earnings are confirmed for Thursday, July 31, 2025.

Is Regeneron Pharmaceuticals (REGN) going to split?

There is no upcoming split for Regeneron Pharmaceuticals.

What sector and industry does Regeneron Pharmaceuticals (REGN) operate in?

Regeneron Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.